Physician
Sutter Bay Medical Foundation
Sutter Bay Medical Foundation was paid $18.88M by Medicaid between Jan 2018 and Nov 2024, across 205 billing codes. Its largest line is 99233, hospital visit by a doctor, follow-up day (complex) — 10% of everything it billed.
33Billing provider infoSUTTER BAY MEDICAL FOUNDATION
SACRAMENTO, CA 95816
SACRAMENTO, CA 95816
33aNPI1003267196assigned 06/29/2016
33bProvider typeObstetrics & Gynecology Physician
28Total paid$18.88M
24GClaims437,823
24DCodes billed205
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Obstetrics & Gynecology Physician providers in California
Rank by total paid#3 of 791
Median peer was paid$67K
This provider vs. median283×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LOPES, KRISTA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 63,397 | $2.28M | |
| 2019 | 47,438 | $1.93M | |
| 2020 | 46,989 | $2.03M | |
| 2021 | 65,579 | $2.86M | |
| 2022 | 70,095 | $3.00M | |
| 2023 | 75,167 | $3.54M | |
| 2024incomplete | 69,158 | $3.24M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 10% | 35,892 | 11,825 | $1.91M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.3% | 56,437 | 54,021 | $1.75M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 7.8% | 12,833 | 11,685 | $1.48M |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 6.9% | 14,903 | 9,135 | $1.31M |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 5.7% | 31,928 | 19,966 | $1.08M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 5.4% | 13,095 | 11,561 | $1.02M |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 5.4% | 9,199 | 5,889 | $1.01M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 4.9% | 17,508 | 16,248 | $927K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 3.9% | 11,373 | 7,693 | $743K |
| 76813 | 3.6% | 8,567 | 6,079 | $682K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 2.4% | 12,515 | 7,361 | $462K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 2.1% | 693 | 429 | $397K |
193 more codes
| 76801 | 2.1% | 6,972 | $397K | |
| 70450 | Computed tomography, head or brain; without contrast material | 1.9% | 7,980 | $362K |
| 76642 | 1.9% | 7,130 | $358K | |
| 77066 | Tomosynthesis, mammo | 1.6% | 3,281 | $310K |
| 71045 | Radiologic examination, chest; single view | 1.5% | 28,247 | $290K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.5% | 2,111 | $278K |
| 99223 | Prolong inpt eval add15 m | 1.4% | 3,070 | $257K |
| 99213 | Doctor's office visit, returning patient (routine) | 1.3% | 21,400 | $252K |
| 99232 | Hospital visit by a doctor, follow-up day | 1.0% | 4,670 | $193K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 5,614 | $185K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 18,351 | $166K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 2,318 | $159K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 837 | $158K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 3,688 | $152K |
| 93000 | <1% | 7,735 | $147K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 2,516 | $144K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 1,481 | $142K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 8,989 | $131K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,355 | $128K |
| 76830 | Ultrasound, transvaginal | <1% | 2,797 | $118K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 2,155 | $116K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 2,344 | $111K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 578 | $105K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 3,105 | $103K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 5,065 | $87K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 2,068 | $81K |
| 59025 | Fetal non-stress test | <1% | 13,878 | $80K |
| 77065 | Tomosynthesis, mammo | <1% | 718 | $51K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 1,075 | $49K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 852 | $49K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 579 | $44K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 389 | $41K |
| 0001A | <1% | 1,055 | $37K | |
| S0265 | Genetic counseling, under physician supervision, each 15 minutes | <1% | 1,030 | $37K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 482 | $37K |
| 0002A | <1% | 925 | $36K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 200 | $33K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 687 | $31K |
| 99152 | <1% | 653 | $30K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 629 | $26K |
| 99205 | Prolong outpt/office vis | <1% | 424 | $22K |
| 91322 | <1% | 162 | $21K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 133 | $21K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 136 | $21K |
| 97010 | <1% | 684 | $18K | |
| 99242 | <1% | 467 | $18K | |
| 70496 | <1% | 192 | $16K | |
| 90686 | <1% | 2,660 | $16K | |
| 70498 | <1% | 184 | $16K | |
| 99245 | <1% | 161 | $15K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 295 | $15K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 256 | $14K |
| 0012A | <1% | 375 | $14K | |
| 0011A | <1% | 407 | $14K | |
| 43259 | <1% | 104 | $13K | |
| 64615 | <1% | 103 | $13K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 409 | $12K |
| 80053 | Comprehensive metabolic panel | <1% | 1,994 | $12K |
| 71250 | <1% | 226 | $12K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 79 | $11K |
| 73630 | <1% | 779 | $11K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 78 | $9K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 102 | $9K |
| 76770 | <1% | 224 | $9K | |
| 97803 | <1% | 427 | $9K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 420 | $8K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 1,141 | $7K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,016 | $7K |
| 94729 | <1% | 236 | $7K | |
| 93296 | <1% | 294 | $7K | |
| 95720 | <1% | 22 | $7K | |
| 90480 | <1% | 201 | $7K | |
| 94060 | <1% | 147 | $6K | |
| 97165 | <1% | 164 | $6K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 125 | $6K |
| 73030 | <1% | 409 | $6K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,646 | $5K |
| 99255 | <1% | 53 | $5K | |
| 95806 | <1% | 16 | $5K | |
| 94727 | <1% | 111 | $5K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 122 | $5K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,660 | $5K |
| 76536 | <1% | 125 | $4K | |
| 74328 | <1% | 156 | $4K | |
| 80061 | Lipid panel | <1% | 1,153 | $4K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 368 | $4K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 327 | $4K |
| 73221 | <1% | 31 | $4K | |
| 72141 | <1% | 21 | $4K | |
| 90653 | <1% | 45 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 331 | $3K |
| 59425 | <1% | 30 | $3K | |
| 92551 | <1% | 1,534 | $3K | |
| 73562 | <1% | 232 | $3K | |
| 0071A | <1% | 77 | $3K | |
| 43264 | <1% | 14 | $3K | |
| 93015 | <1% | 26 | $3K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 337 | $3K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 56 | $3K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 137 | $3K |
| 93248 | <1% | 87 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 411 | $3K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 42 | $3K |
| 93971 | <1% | 101 | $3K | |
| 43274 | <1% | 13 | $2K | |
| 51798 | <1% | 45 | $2K | |
| 73610 | <1% | 172 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 252 | $2K |
| 93244 | <1% | 54 | $2K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 520 | $2K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 100 | $2K |
| 96415 | <1% | 20 | $2K | |
| 0072A | <1% | 41 | $2K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 55 | $2K |
| 94726 | <1% | 120 | $1K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 17 | $1K |
| 73130 | <1% | 90 | $1K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 28 | $1K |
| 0134A | <1% | 87 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 395 | $1K |
| 76937 | <1% | 100 | $1K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 396 | $1K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 503 | $1K |
| 77001 | <1% | 67 | $1K | |
| 74174 | <1% | 12 | $1K | |
| 96367 | <1% | 16 | $1K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 325 | $967.91 |
| 76820 | <1% | 39 | $936.24 | |
| 97802 | <1% | 13 | $934.86 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 30 | $885.39 |
| 90651 | <1% | 13 | $867.48 | |
| 95251 | <1% | 25 | $810.32 | |
| 82565 | <1% | 100 | $765.56 | |
| 82728 | <1% | 218 | $737.96 | |
| 90656 | <1% | 126 | $706.12 | |
| 93295 | <1% | 13 | $702.38 | |
| 77012 | <1% | 13 | $687.41 | |
| 96411 | <1% | 19 | $664.59 | |
| 74018 | <1% | 56 | $601.56 | |
| 73110 | <1% | 41 | $593.96 | |
| 73502 | <1% | 31 | $524.72 | |
| 0064A | <1% | 14 | $520.00 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 133 | $448.11 |
| 83550 | <1% | 169 | $447.24 | |
| 93294 | <1% | 16 | $429.91 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 339 | $396.57 |
| 85027 | <1% | 134 | $377.75 | |
| 83540 | <1% | 172 | $367.06 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 32 | $351.18 |
| 90715 | <1% | 12 | $350.98 | |
| 99153 | Mod sedat endo service >5yrs | <1% | 13 | $329.98 |
| 86803 | <1% | 201 | $327.53 | |
| 96127 | <1% | 41 | $295.16 | |
| 72100 | <1% | 18 | $282.71 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 144 | $250.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 17 | $231.94 |
| 93246 | <1% | 12 | $230.52 | |
| 90670 | <1% | 29 | $177.75 | |
| 81002 | <1% | 155 | $167.69 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 339 | $157.61 |
| 73564 | <1% | 12 | $153.54 | |
| 82607 | <1% | 75 | $149.97 | |
| 90698 | <1% | 15 | $135.00 | |
| 90680 | <1% | 14 | $126.00 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 26 | $118.20 |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 12 | $112.96 |
| 93325 | <1% | 16 | $98.33 | |
| 99173 | <1% | 886 | $87.86 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 40 | $76.81 |
| 99422 | <1% | 17 | $76.28 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 28 | $69.16 |
| 11056 | <1% | 12 | $68.86 | |
| 86592 | <1% | 156 | $55.84 | |
| 99070 | <1% | 14 | $51.51 | |
| 81001 | <1% | 90 | $50.78 | |
| 90688 | <1% | 65 | $38.00 | |
| 84439 | <1% | 13 | $30.31 | |
| 81003 | <1% | 39 | $21.19 | |
| 91200 | <1% | 86 | $21.02 | |
| 90658 | <1% | 13 | $18.00 | |
| 85018 | <1% | 25 | $4.52 | |
| 86706 | <1% | 26 | $3.68 | |
| G9012 | Other specified case management service not elsewhere classified | 0% | 153 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 93 | $0.00 |
| 80050 | General health panel | 0% | 70 | $0.00 |
| 90694 | 0% | 44 | $0.00 | |
| 99000 | 0% | 42 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 13 | $0.00 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 12 | $0.00 |
| 98968 | 0% | 56 | $0.00 | |
| 99221 | 0% | 14 | $0.00 | |
| 90662 | 0% | 41 | $0.00 | |
| 90461 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLOPES, KRISTA (SH VP, QUALITY, SAFETY, PATIENT EDU)
| Provider | Location | Paid |
|---|---|---|
| Sutter Valley Medical Foundation | Sacramento, CA | $41.25M |
| Sutter Bay Medical Foundation | Palo Alto, CA | $19.65M |
| Sutter Valley Medical Foundation | Modesto, CA | $18.22M |
| Sutter Valley Medical Foundation | Yuba City, CA | $12.47M |
| Sutter Bay Medical Foundation | Orinda, CA | $6.77M |
| Sutter Valley Medical Foundation | Fairfield, CA | $3.92M |
| Sutter Valley Medical Foundation | Sacramento, CA | $3.85M |
| Sutter Valley Medical Foundation | Yuba City, CA | $2.45M |
| Sutter Valley Medical Foundation | Brownsville, CA | $1.37M |
| Sutter Valley Medical Foundation | Plymouth, CA | $407K |
| Sutter Valley Medical Foundation | Modesto, CA | $303K |
| Sutter Valley Medical Foundation | Yuba City, CA | $272K |
| Sutter Valley Medical Foundation | Yuba City, CA | $93K |
| Sutter Bay Medical Foundation | Santa Cruz, CA | $77K |
| Sutter Medical Foundation | Yuba City, CA | $31K |
| Sutter Bay Medical Foundation | Palo Alto, CA | $29K |
| Sutter Bay Medical Foundation | Mountain View, CA | $22K |
| Sutter Bay Medical Foundation | Palo Alto, CA | $11K |
| Sutter Bay Medical Foundation | Los Gatos, CA | $10K |
| Sutter Bay Medical Foundation | Palo Alto, CA | $10K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.